Lipika Chablani: AAPS 2011 Profile and Podcast
Lipika Chablani
Lipika Chablani (PhD Candidate)
Department of Pharmaceutical Sciences
College of Pharmacy and Health Sciences
Mercer University, Atlanta, Georgia 30341, USA.
Thesis Title: Formulation of Novel Particulate Breast Cancer Vaccines using Spray Drying and In Vivo Evaluation of Vaccine Efficacy
M.S. in Industrial Pharmacy, College of Pharmacy and Health Sciences, Buies Creek, Campbell University, North Carolina 27506.
B.Pharm., K.M.Kundnani College of Pharmacy, Mumbai University, Mumbai, India 400018.
View Full Research Presentation
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
